Peking University People's Hospital
China's premier haematology destination and one of the nation's top academic medical centres. Founded in 1918, PKUPH has built a globally recognised haematology programme — including China's largest allogenic bone marrow transplantation unit — alongside national-level excellence in orthopaedics, ophthalmology, and cardiology.
Overview & History
Over a century of academic medicine — and a haematology programme that has transformed outcomes for leukaemia and lymphoma patients across Asia.
Peking University People's Hospital (北京大学人民医院, "Renminyiyuan") was established in 1918 and became one of China's first modern general hospitals. Over its 100+ year history, it has developed into a comprehensive academic medical centre excelling across multiple specialties — most notably in haematology, where it occupies the undisputed #1 position in China.
The hospital's haematology department, led by generations of pioneering researchers, established the nationally adopted protocols for acute leukaemia treatment and operates China's largest allogeneic bone marrow transplantation programme. The unit performs over 600 allogeneic haematopoietic stem cell transplants annually — a volume few centres in the world can match — and has developed the internationally recognised "Beijing Protocol" for haploidentical (half-matched) transplantation that has been adopted by programmes in over 40 countries.
Why Choose PKUPH
- ✓ China's #1 haematology ranking — consecutive years
- ✓ Inventors of the "Beijing Protocol" for haploidentical BMT — used in 40+ countries
- ✓ 600+ allogeneic transplants annually — world-leading volume
- ✓ National Key Disciplines in both orthopaedics and ophthalmology
- ✓ CAR-T cell therapy for refractory haematological malignancies
- ✓ 45-65% cost savings vs. equivalent BMT programmes in USA or Australia
Medicsino 6-Dimension Scorecard
Signature Specialties
Haematology & BMT
China's #1 haematology centre. Leukaemia, lymphoma, myeloma, aplastic anaemia, and MDS. Inventors of the Beijing Protocol for haploidentical transplantation — 600+ allogeneic BMTs annually.
CAR-T Cell Therapy
Approved CAR-T products for B-cell lymphoma and ALL. Academic trial access for novel constructs. One of China's leading CAR-T manufacturing and infusion centres.
Orthopaedics
National Key Discipline. Joint replacement (knee, hip), spinal surgery, sports medicine, and bone tumour resection. Nationally cited for revision arthroplasty outcomes.
Ophthalmology
National Key Discipline. Retinal surgery, glaucoma, corneal transplantation, and paediatric ophthalmology. High-volume cataract and refractive surgery centre.
Cardiology
Interventional cardiology, structural heart disease, electrophysiology, and heart failure. Cardiology-haematology co-management for chemotherapy cardiotoxicity monitoring.
Gastroenterology
Liver disease, inflammatory bowel disease, GI endoscopy, and GI oncology. Close collaboration with haematology for gastrointestinal complications of BMT.
International Patient Services
Haematology Case Review
Submit bone marrow biopsy slides, cytogenetics, FISH, and flow cytometry results for expert review by PKUPH haematologists. Written assessment within 5 business days.
BMT Programme Evaluation
Comprehensive pre-transplant evaluation including HLA typing coordination, donor search strategy, and detailed cost projection — all arranged before travel.
Bilingual Case Records
Complete bone marrow transplant records, chemotherapy logs, and discharge summaries provided in English. Ongoing laboratory results transmitted digitally to home oncologist.
Long-Stay Coordination
BMT requires 4–6 months in China. Medicsino arranges furnished apartment accommodation, visa extensions, caregiver coordination, and social support throughout the stay.
Family Support Services
Haematology patients typically come with family caregivers. Medicsino arranges family accommodation, airport support, city orientation, and local SIM cards on arrival.
Post-Transplant Follow-Up
Remote monitoring protocol for graft-versus-host disease, infection surveillance, and immune reconstitution. Monthly video consultations with treating haematologist.
Hospital Gallery
Photos represent Peking University People's Hospital — the birthplace of the “Beijing Protocol” for haploidentical BMT.
Available Packages at This Hospital
Haematology Diagnostic Panel
- Bone marrow biopsy + aspirate
- Flow cytometry (full immunophenotyping)
- Cytogenetics + FISH panel
- Molecular mutation panel (NGS)
- Haematologist consultation + English report
Induction Chemotherapy
- Full disease staging & MDT review
- Induction chemotherapy course (1 cycle)
- Central line insertion & management
- Anti-infective prophylaxis & supportive care
- English treatment plan for home oncologist
Allogeneic Bone Marrow Transplant
- Full pre-transplant workup & conditioning
- Allogeneic HSCT (haploidentical available)
- 100-day in-hospital monitoring
- GVHD management & infection prophylaxis
- Comprehensive English BMT records
Patient Testimonials
Plan Your Treatment at Peking University People's Hospital
For haematological conditions, send us your bone marrow results, cytogenetics, and treatment history. For other specialties, share your diagnosis and imaging. We'll connect you with the right team within 48 hours.